Table 1 Baseline characteristics of subjects in discovery and replication phases.
Variables | Non-DCI (n = 27) | Discovery | Non-DCI (n = 24) | Replication | ||
|---|---|---|---|---|---|---|
DCI (n = 13) | p-value | DCI (n = 12) | p-value | |||
Clinical findings | ||||||
Female | 15 (55.6%) | 10 (76.9%) | 0.398 | 17 (70.8%) | 8 (66.7%) | 0.801 |
Age, years | 53.4 ± 12.2 | 53.2 ± 6.7 | 0.970 | 59.9 ± 8.3 | 58.4 ± 8.4 | 0.601 |
Hypertension | 9 (33.3%) | 2 (15.4%) | 0.175 | 11 (45.8%) | 7 (58.3%) | 0.486 |
Diabetes mellitus | 3 (11.1%) | 0 (0.00%) | 0.192 | 2 (8.3%) | 2 (16.7%) | 0.460 |
Hyperlipidemia | 4 (14.8%) | 1 (7.7%) | 0.458 | 1 (4.2%) | 1 (8.3%) | 0.612 |
Smoking | 5 (18.5%) | 4 (30.8%) | 0.505 | 2 (8.3%) | 1 (8.3%) | 1.000 |
Radiologic findings | ||||||
HH grade 4 and 5 | 7 (25.9%) | 6 (46.2%) | 0.311 | 7 (29.2%) | 7 (58.3%) | 0.095 |
Fisher grade 3 and 4 | 20 (74.1%) | 12 (92.3%) | 0.513 | 17 (70.8%) | 10 (83.3%) | 0.421 |
Anterior location | 21 (77.8%) | 11 (84.6%) | 0.870 | 19 (79.2%) | 9 (75.0%) | 0.780 |
Treatment | ||||||
Coil embolization | 22 (81.5%) | 10 (76.9%) | 0.326 | 19 (79.2%) | 9 (75.0%) | 0.780 |
